Related MeSH Hierarchy (4)
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Protein Disorders » Hypergammaglobulinemia » Monoclonal Gammopathy of Undetermined Significance
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Protein Disorders » Paraproteinemias » Monoclonal Gammopathy of Undetermined Significance
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Hypergammaglobulinemia » Monoclonal Gammopathy of Undetermined Significance
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Paraproteinemias » Monoclonal Gammopathy of Undetermined Significance
Description
Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia. MeSH
Hierarchy View
Subtype Terms (1)
Schnitzler Syndrome
6 drugs (3 approved, 3 experimental)
Phase 2 Indicated Drugs (13)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (6)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
